Safety study of VVN432 nasal spray
Part of Ear, nose & throat clinical trials.
This trial tests a nasal spray called VVN432 in healthy volunteers and people with chronic sinusitis. It checks if the spray is safe and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- For healthy part: you must be in good general health.
- For sinusitis part: you have had sinus symptoms like stuffy nose, mucus, facial pain, or reduced smell for more than 4 weeks.
- Your body mass index (BMI) is between 18.5 and 28.0.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You have not taken any investigational drug in the last 12 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a nasal spray made from mastic oil combined with a lower dose of a standard steroid medication (mometasone) for people with chronic sinusitis. It aims to see if this combination is effective in reducing symptoms.
This study tests a new sinus stent that slowly releases medication to treat chronic sinusitis. It may reduce symptoms and help avoid repeated surgeries.
This study tests an injection called LP-003 that may help reduce nasal polyps and improve breathing. It's for people whose symptoms are not controlled by standard treatments like steroid sprays or surgery.
This study tests a new drug called BBT002 in healthy people and in patients with chronic sinusitis and nasal polyps, with or without asthma. It aims to see if the drug is safe and effective for reducing symptoms.
This trial tests a new medication called CM512 for people with chronic sinusitis and nasal polyps. It aims to reduce nasal congestion and improve symptoms.
This study collects information from people with chronic rhinosinusitis and nasal polyps in both nostrils. By tracking patients over time, researchers hope to learn more about the condition and how to improve care.
Hear when a new Chronic Rhinosinusitis (CRS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.